u.s. epidemiologist witness at canadian inquiry

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update U.S. Epidemiologist Witness at Canadian Inquiry
March 9, 1995

Toronto Globe and Mail (03/07/95) P. A4 The first witness in the final stage of the $13.5 million judicial inquiry into Canada's blood system will be Dr. Donald Francis, a former epidemiologist at the U.S. Centers for Disease Control and Prevention. Francis has been one of the most acerbic critics of governments' slow response to the AIDS epidemic. In his interim report last month, Mr. Justice Horace Krever, who is heading the commission of inquiry, warned that the tainted blood tragedy could be repeated with a new contaminating agent. He said that changes are necessary to "minimize the likelihood of such a calamity." The final report, to be completed by the end of the year, will examine the decisions that led to the infection of more than 1,002 Canadian hemophiliacs and transfusion recipients with HIV during the early 1980s. The commission's final report will also recommend a complete revamping of the blood system.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 COLORADO: Boulder Groups Honor More Than 150 Local AIDS Victims PENNSYLVANIA: Area Residents Screened for Hepatitis C on Sunday COLORADO: Peer to Peer: Teens Work to Educate Peers on Pregnancy, STDs at CCHS OREGON: Portland Barefoot 3 x 3 Benefit Tournament to Draw Hundreds to Northeast Portland TEXAS: Temple - Wellness and Sexual Health Classes Helping Kids to Abstain CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C JAMAICA: AIDS Awareness Workshop Organised for High-School Students EUROPE: EU Issues Stringent Sharps Regulations CALIFORNIA: $50,000 Prisoner Prescription: Inmates Get Expensive Hepatitis C Treatment Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg Varsities danger zones as US cuts AIDS funds THE BAHAMAS: U.S. Charge d'Affaires Presents $14,000 to Bahamian Organizations to Promote HIV/AIDS Awareness 2012 US medicine sales show shifts by drug type US researchers develop new tool in HIV vaccine fight MET-Rx® Launches MET-Rx® Cares U.S. Charitable Giving Program Pakistani gay says life easier at home than in US KOREA: U.S. Non-Profit Group to Build Tuberculosis Center in Pyongyang Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat AHF Urges Health Plans to Adopt New Routine HIV Testing Recommendation from U.S. Preventative Services Task Force US Task Force Recommends Widespread HIV Testing
Copyright © 1995 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in March 9, 1995. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.